Guided Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Oct '25 Oct 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	20	10	8	15	8	4	Upgrade
Market Cap Growth	304.46%	17.63%	-43.03%	84.30%	101.40%	789.61%	Upgrade
Enterprise Value	25	15	13	18	17	10	Upgrade
Last Close Price	0.24	0.15	0.15	0.30	0.58	0.30	Upgrade
PS Ratio	173.57	1395.66	84.75	1121.44	97.66	38.51	Upgrade
PB Ratio	-3.74	-2.00	-2.18	-5.06	-1.45	-0.36	Upgrade
EV/Sales Ratio	209.68	2134.23	129.38	1364.13	210.72	96.70	Upgrade
Debt / Equity Ratio	-0.41	-0.44	-0.51	-0.78	-0.53	-0.41	Upgrade
Asset Turnover	0.11	0.01	0.04	0.01	0.05	0.08	Upgrade
Inventory Turnover	0.07	0.01	0.11	0.14	0.10	-	Upgrade
Quick Ratio	0.03	0.06	0.12	0.48	0.12	0.02	Upgrade
Current Ratio	0.13	0.19	0.29	0.62	0.29	0.10	Upgrade
Return on Assets (ROA)	-129.56%	-86.48%	-67.47%	-77.07%	-87.09%	-51.98%	Upgrade
Earnings Yield	-13.24%	-24.74%	-42.01%	-29.78%	-26.17%	-7.10%	Upgrade
FCF Yield	-	-11.45%	-21.02%	-10.36%	-20.30%	-47.77%	Upgrade
Buyback Yield / Dilution	-23.64%	-12.14%	-57.30%	-142.99%	-24.24%	-226.07%	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.